Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration

Oral fluid (OF) is a valuable biological alternative for clinical and forensic drug testing. Evaluating OF to plasma (OF/P) cannabinoid ratios provides important pharmacokinetic data on the disposition of drug and factors influencing partition between matrices. Eleven chronic cannabis smokers resided on a closed research unit for 51 days. There were four 5-day sessions of 0, 30, 60, and 120 mg oral ∆9-tetrahydrocannabinol (THC)/day followed by a five-puff smoked cannabis challenge on Day 5. Each session was separated by 9 days ad libitum cannabis smoking. OF and plasma specimens were analyzed for THC and metabolites. During ad libitum smoking, OF/P THC ratios were high (median, 6.1; range, 0.2–348.5) within 1 h after last smoking, decreasing to 0.1–20.7 (median, 2.1) by 13.0–17.1 h. OF/P THC ratios also decreased during 5-days oral THC dosing, and after the smoked cannabis challenge, median OF/P THC ratios decreased from 1.4 to 5.5 (0.04–245.6) at 0.25 h to 0.12 to 0.17 (0.04–5.1) at 10.5 h post-smoking. In other studies, longer exposure to more potent cannabis smoke and oromucosal cannabis spray was associated with increased OF/P THC peak ratios. Median OF/P 11-nor-9-carboxy-THC (THCCOOH) ratios were 0.3–2.5 (range, 0.1–14.7) ng/μg, much more consistent in various dosing conditions over time. OF/P THC, but not THCCOOH, ratios were significantly influenced by oral cavity contamination after smoking or oromucosal spray of cannabinoid products, followed by time-dependent decreases. Establishing relationships between OF and plasma cannabinoid concentrations is essential for making inferences of impairment or other clinical outcomes from OF concentrations.

[1]  Marilyn A Huestis,et al.  Cannabis effects on driving skills. , 2013, Clinical chemistry.

[2]  Reese T. Jones,et al.  Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. , 1992, Journal of analytical toxicology.

[3]  O. Drummer Review: Pharmacokinetics of illicit drugs in oral fluid. , 2005, Forensic science international.

[4]  J. Ramaekers,et al.  Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. , 2007, Journal of analytical toxicology.

[5]  Charles J DiMaggio,et al.  Marijuana use and motor vehicle crashes. , 2012, Epidemiologic reviews.

[6]  Marilyn A Huestis,et al.  Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. , 2012, Journal of analytical toxicology.

[7]  M. Huestis,et al.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. , 2011, Clinical chemistry.

[8]  D. Kuntz,et al.  Detection of THCA in oral fluid by GC-MS-MS. , 2006, Journal of analytical toxicology.

[9]  M. Stitzer,et al.  The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. , 2013, Drug and alcohol dependence.

[10]  W. Hall,et al.  Testing for cannabis in the work-place: a review of the evidence. , 2010, Addiction.

[11]  D. Kelly,et al.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. , 2009, Clinical chemistry.

[12]  M. Huestis,et al.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. , 2010, Journal of chromatography. A.

[13]  D. Kelly,et al.  Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. , 2010, Clinical chemistry.

[14]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[15]  M. Huestis,et al.  Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. , 2011, Clinical chemistry.

[16]  M. Huestis,et al.  Cannabinoid disposition in oral fluid after controlled smoked cannabis. , 2012, Clinical chemistry.

[17]  E. Gallardo,et al.  Current technologies and considerations for drug bioanalysis in oral fluid. , 2009, Bioanalysis.

[18]  M R Moeller,et al.  Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. , 2006, Drug and alcohol dependence.

[19]  George W Rebok,et al.  Drug violations and aviation accidents: findings from the US mandatory drug testing programs. , 2011, Addiction.

[20]  D. Kelly,et al.  Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. , 2011, Clinical chemistry.

[21]  J. Hirvonen,et al.  Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. , 2011, Clinical chemistry.

[22]  R. Frances Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2013 .

[23]  M. Huestis,et al.  Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? , 2013, Drug and alcohol dependence.

[24]  L. Martens,et al.  Review: The physiology of saliva and transfer of drugs into saliva. , 2005, Forensic science international.

[25]  J. Ramaekers,et al.  Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. , 2010, Journal of analytical toxicology.

[26]  M. Huestis,et al.  Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. , 2007, Journal of chromatography. A.

[27]  Marilyn A Huestis,et al.  Oral fluid testing for drugs of abuse. , 2009, Clinical chemistry.

[28]  A. Verstraete,et al.  Relationship Between Oral Fluid and Blood Concentrations of Drugs of Abuse in Drivers Suspected of Driving Under the Influence of Drugs , 2009, Therapeutic drug monitoring.

[29]  A. Smith,et al.  Cannabis use, cognitive performance and mood in a sample of workers , 2006, Journal of psychopharmacology.

[30]  J. Ramaekers,et al.  Dose related risk of motor vehicle crashes after cannabis use. , 2004, Drug and alcohol dependence.

[31]  M. Huestis Cannabis ( Marijuana ) — Effects on Human Behavior and Performance , 2002 .

[32]  N. Samyn,et al.  On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users , 2000, International Journal of Legal Medicine.

[33]  M. Huestis,et al.  Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. , 1992, Journal of analytical toxicology.